Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk.

Landecho MF, Tuero C, Valentí V, Bilbao I, de la Higuera M, Frühbeck G.

Nutrients. 2019 Nov 5;11(11). pii: E2664. doi: 10.3390/nu11112664. Review.

2.

"Non-Touch" Vena Cava Technique as an Improvement in Combined Lung and Liver Procurement in Controlled Donation After Circulatory Death.

Caralt M, Bello I, Sandiumenge A, Dopazo C, Pando E, Molino JA, Lázaro JL, Bilbao I, Pont T, Solé J, Charco R.

Transplant Proc. 2019 Jan - Feb;51(1):9-11. doi: 10.1016/j.transproceed.2018.02.216. Epub 2019 Jan 14.

PMID:
30655141
3.

Efficacy and safety of administering oral misoprostol by titration compared to vaginal misoprostol and dinoprostone for cervical ripening and induction of labour: study protocol for a randomised clinical trial.

Lapuente-Ocamica O, Ugarte L, Lopez-Picado A, Sanchez-Refoyo F, Lasa IL, Echevarria O, Álvarez-Sala J, Fariñas A, Bilbao I, Barbero L, Vicarregui J, Hernanz Chaves R, Paz Corral D, Lopez-Lopez JA.

BMC Pregnancy Childbirth. 2019 Jan 8;19(1):14. doi: 10.1186/s12884-018-2132-3.

4.

Reply.

Quintero J, Molera C, Juamperez J, Redecillas S, Meavilla S, Nuñez R, García-Volpe C, Del Toro M, Garcia-Cazorla Á, Ortega J, Segarra Ó, de Carpi JM, Bilbao I, Charco R.

Liver Transpl. 2019 Jan;25(1):178-179. doi: 10.1002/lt.25389. No abstract available.

PMID:
30472769
5.

The Role of Liver Transplantation in Propionic Acidemia.

Quintero J, Molera C, Juamperez J, Redecillas S, Meavilla S, Nuñez R, García C, Del Toro M, Garcia Á, Ortega J, Segarra Ó, de Carpi JM, Bilbao I, Charco R.

Liver Transpl. 2018 Dec;24(12):1736-1745. doi: 10.1002/lt.25344.

PMID:
30242960
6.

Retrospective Study of Cystic Echinococcosis in a Recent Cohort of a Referral Center for Liver Surgery.

Escolà-Vergé L, Salvador F, Sánchez-Montalvá A, Escudero-Fernández JM, Sulleiro E, Rando A, Bilbao I, Lázaro JL, Serres X, Salvador J, Molina I.

J Gastrointest Surg. 2019 Jun;23(6):1148-1156. doi: 10.1007/s11605-018-3971-y. Epub 2018 Sep 21.

PMID:
30242646
7.

Colorectal cancer screening program using FIT: quality of colonoscopy varies according to hospital type.

Portillo I, Idigoras I, Bilbao I, Arana-Arri E, Fernández-Landa MJ, Hurtado JL, Sarasaqueta C, Bujanda L; EUSKOLON study investigators .

Endosc Int Open. 2018 Sep;6(9):E1149-E1156. doi: 10.1055/a-0655-1987. Epub 2018 Sep 11.

8.

Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction.

Dopazo C, Charco R, Caralt M, Pando E, Lázaro JL, Gómez-Gavara C, Castells L, Bilbao I.

Can J Gastroenterol Hepatol. 2018 Aug 16;2018:1672621. doi: 10.1155/2018/1672621. eCollection 2018.

9.

Quality indicators and patient satisfaction in colonoscopy.

Fernández-Landa MJ, Aginagalde AH, Arana-Arri E, Bujanda L, Idígoras I, Bilbao I, Portillo I, Jover R.

Gastroenterol Hepatol. 2019 Feb;42(2):73-81. doi: 10.1016/j.gastrohep.2018.07.006. Epub 2018 Aug 28. English, Spanish.

PMID:
30170708
10.

Screening colonoscopy and risk of adverse events among individuals undergoing fecal immunochemical testing in a population-based program: A nested case-control study.

Arana-Arri E, Imaz-Ayo N, Fernández MJ, Idigoras I, Bilbao I, Bujanda L, Bao F, Ojembarrena E, Gil I, Gutiérrez-Ibarluzea I, Portillo I.

United European Gastroenterol J. 2018 Jun;6(5):755-764. doi: 10.1177/2050640618756105. Epub 2018 Jan 24.

11.

Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical test.

Portillo I, Arana-Arri E, Gutiérrez-Ibarluzea I, Bilbao I, Luis Hurtado J, Sarasqueta C, Idigoras I, Bujanda L; EUSKOLON Study Investigators.

Eur J Public Health. 2018 Dec 1;28(6):1143-1148. doi: 10.1093/eurpub/cky109.

PMID:
29982586
12.

Prevalence and progression of chronic kidney disease after liver transplant: a prospective, real-life, observational, two-year multicenter study.

Herrero JI, Cuervas-Mons V, Gómez-Bravo MÁ, Fabregat J, Otero A, Bilbao I, Salcedo MM, González-Diéguez ML, Fernández JR, Serrano MT, Jiménez M, Rodrigo JM, Narváez I, Sánchez G.

Rev Esp Enferm Dig. 2018 Sep;110(9):538-543. doi: 10.17235/reed.2018.5431/2017.

13.

The role of extra-pancreatic infections in the prediction of severity and local complications in acute pancreatitis.

Pando E, Alberti P, Hidalgo J, Vidal L, Dopazo C, Caralt M, Blanco L, Gómez-Gavara C, Bilbao I, Balsells J, Charco R.

Pancreatology. 2018 May 19. pii: S1424-3903(18)30587-8. doi: 10.1016/j.pan.2018.05.481. [Epub ahead of print]

PMID:
29802078
14.

Role of Biodegradable Stents as Part of Treatment of Biliary Strictures after Pediatric and Adult Liver Transplantation: An Observational Single-Center Study.

Dopazo C, Diez I, Quintero J, Curell A, González-Junyent C, Caralt M, Pando E, Lázaro JL, Molino JA, Juamperez J, Castells L, Pérez M, Bilbao I, Segarra A, Charco R.

J Vasc Interv Radiol. 2018 Jun;29(6):899-904. doi: 10.1016/j.jvir.2018.02.007.

PMID:
29798761
15.

Pneumatocele during sorafenib therapy: first report of an unusual complication.

Sangro P, Bilbao I, Fernández-Ros N, Iñarrairaegui M, Zulueta J, Bilbao JI, Sangro B.

Oncotarget. 2017 Dec 22;9(5):6652-6656. doi: 10.18632/oncotarget.23599. eCollection 2018 Jan 19.

16.

Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients.

Gómez-Bravo MA, Apellaniz-Ruiz M, Salcedo M, Fondevila C, Suarez F, Castellote J, Rufian S, Pons JA, Bilbao I, Alamo JM, Millán O, Brunet M, Rodríguez-Antona C.

Pharmacogenet Genomics. 2018 Feb;28(2):41-48. doi: 10.1097/FPC.0000000000000321.

PMID:
29256966
17.

Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.

Bilbao I, Egaña N, García C, Olaizola I.

Endocrinol Diabetes Nutr. 2017 Dec;64(10):564-566. doi: 10.1016/j.endinu.2017.08.007. Epub 2017 Nov 11. English, Spanish. No abstract available.

PMID:
29137963
18.

Successful long-term outcome of pediatric liver-kidney transplantation: a single-center study.

Quintero Bernabeu J, Juamperez J, Muñoz M, Rodriguez O, Vilalta R, Molino JA, Asensio M, Bilbao I, Ariceta G, Rodrigo C, Charco R.

Pediatr Nephrol. 2018 Feb;33(2):351-358. doi: 10.1007/s00467-017-3782-5. Epub 2017 Aug 25.

PMID:
28842757
19.

Conversion from twice-daily to once-daily tacrolimus formulation in pediatric liver transplant recipients - a long-term prospective study.

Quintero J, Juampérez J, Ortega J, Molino JA, Castells L, Bilbao I, Rodrigo C, Charco R.

Transpl Int. 2018 Jan;31(1):38-44. doi: 10.1111/tri.13037. Epub 2017 Sep 27.

20.

Successful liver transplantation despite donor-transmitted ESBL-producing Klebsiella pneumoniae infection: Case report and review of the literature.

Escolà-Vergé L, Los-Arcos I, José González-López J, Lung M, Bilbao I, Farré M, Pont T, Sandiumenge A, Gavaldà J, Len O.

Transpl Infect Dis. 2017 Oct;19(5). doi: 10.1111/tid.12743. Epub 2017 Aug 2. Review.

PMID:
28691772
21.

Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain).

Portillo I, Arana-Arri E, Idigoras I, Bilbao I, Martínez-Indart L, Bujanda L, Gutierrez-Ibarluzea I.

World J Gastroenterol. 2017 Apr 21;23(15):2731-2742. doi: 10.3748/wjg.v23.i15.2731.

22.

Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study.

Agüero F, Forner A, Valdivieso A, Blanes M, Barcena R, Manzardo C, Rafecas A, Castells L, Abradelo M, Barrera-Baena P, González-Diéguez L, Salcedo M, Serrano T, Jiménez-Pérez M, Herrero JI, Gastaca M, Aguilera V, Fabregat J, Del Campo S, Bilbao I, Romero CJ, Moreno A, Rimola A, Miro JM; FIPSE Investigators.

Liver Transpl. 2017 May;23(5):645-651. doi: 10.1002/lt.24741.

23.

Isolated bilateral Tapia's syndrome after liver transplantation: A case report and review of the literature.

Bilbao I, Dopazo C, Caralt M, Castells L, Pando E, Gantxegi A, Charco R.

World J Hepatol. 2016 Dec 28;8(36):1637-1644. doi: 10.4254/wjh.v8.i36.1637.

24.

 Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant.

Castells L, Llaneras J, Campos-Varela I, Bilbao I, Crespo M, Len O, Rodríguez-Frías F, Charco R, Salcedo T, Esteban JI, Esteban-Mur R.

Ann Hepatol. 2017 Jan-Feb 2017;16(1):86-93. doi: 10.5604/16652681.1226819.

25.

Sofosbuvir and Daclatasvir in Mono- and HIV-coinfected Patients with Recurrent Hepatitis C After Liver Transplant.

Castells L, Llaneras J, Campos-Varela I, Bilbao I, Crespo M, Len O, Rodríguez-Frías F, Charco R, Salcedo T, Ignacio Esteban J, Esteban-Mur R.

Ann Hepatol. 2017 Jan - Feb;16(1):86-93. doi: 10.5604/16652681.1226819.

26.

Does Matching Donor-Recipient Age Affect Long-Term Survival in Liver Transplantation?

Dopazo C, Bilbao I, Castells L, Caralt M, Fernández de Sevilla E, Lázaro JL, Charco R.

Ann Transplant. 2016 Nov 18;21:708-716.

27.

Safety and Efficacy of Early Everolimus When Calcineurin Inhibitors Are Not Recommended in Orthotopic Liver Transplantation.

Gastaca M, Bilbao I, Jimenez M, Bustamante J, Dopazo C, Gonzalez R, Charco R, Santoyo J, Ortiz de Urbina J.

Transplant Proc. 2016 Sep;48(7):2506-2509. doi: 10.1016/j.transproceed.2016.08.027.

PMID:
27742336
28.

Acute Antibody-Mediated Rejection as Cause of Late Liver Allograft Failure: A Case Report.

Vellalta G, Dopazo C, Bilbao I, Castells L, Sapisochin G, Lázaro JL, Montero Á, Salcedo MT, Caralt M, Charco R.

Transplant Proc. 2015 Dec;47(10):3016-9. doi: 10.1016/j.transproceed.2015.10.036.

PMID:
26707330
29.

Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [(18)F]-tetrafluoroborate.

Marti-Climent JM, Collantes M, Jauregui-Osoro M, Quincoces G, Prieto E, Bilbao I, Ecay M, Richter JA, Peñuelas I.

EJNMMI Res. 2015 Dec;5(1):70. doi: 10.1186/s13550-015-0148-5. Epub 2015 Dec 3.

30.

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.

Geissler EK, Schnitzbauer AA, Zülke C, Lamby PE, Proneth A, Duvoux C, Burra P, Jauch KW, Rentsch M, Ganten TM, Schmidt J, Settmacher U, Heise M, Rossi G, Cillo U, Kneteman N, Adam R, van Hoek B, Bachellier P, Wolf P, Rostaing L, Bechstein WO, Rizell M, Powell J, Hidalgo E, Gugenheim J, Wolters H, Brockmann J, Roy A, Mutzbauer I, Schlitt A, Beckebaum S, Graeb C, Nadalin S, Valente U, Turrión VS, Jamieson N, Scholz T, Colledan M, Fändrich F, Becker T, Söderdahl G, Chazouillères O, Mäkisalo H, Pageaux GP, Steininger R, Soliman T, de Jong KP, Pirenne J, Margreiter R, Pratschke J, Pinna AD, Hauss J, Schreiber S, Strasser S, Klempnauer J, Troisi RI, Bhoori S, Lerut J, Bilbao I, Klein CG, Königsrainer A, Mirza DF, Otto G, Mazzaferro V, Neuhaus P, Schlitt HJ.

Transplantation. 2016 Jan;100(1):116-25. doi: 10.1097/TP.0000000000000965.

31.

Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma.

Agüero F, Forner A, Manzardo C, Valdivieso A, Blanes M, Barcena R, Rafecas A, Castells L, Abradelo M, Torre-Cisneros J, Gonzalez-Dieguez L, Salcedo M, Serrano T, Jimenez-Perez M, Herrero JI, Gastaca M, Aguilera V, Fabregat J, Del Campo S, Bilbao I, Romero CJ, Moreno A, Rimola A, Miro JM; FIPSE Investigators.

Hepatology. 2016 Feb;63(2):488-98. doi: 10.1002/hep.28321. Epub 2016 Jan 4.

PMID:
26516761
32.

In Vivo ¹⁸F-FDG-PET Imaging in Mouse Atherosclerosis.

Mateo J, Bilbao I, Vaquero JJ, Ruiz-Cabello J, España S.

Methods Mol Biol. 2015;1339:377-86. doi: 10.1007/978-1-4939-2929-0_28.

PMID:
26445805
33.

Reply.

Bilbao I, Guilera M.

Liver Transpl. 2016 Jan;22(1):134-5. doi: 10.1002/lt.24354. No abstract available.

34.

Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.

Bilbao I, Salcedo M, Gómez MA, Jimenez C, Castroagudín J, Fabregat J, Almohalla C, Herrero I, Cuervas-Mons V, Otero A, Rubín A, Miras M, Rodrigo J, Serrano T, Crespo G, De la Mata M, Bustamante J, Gonzalez-Dieguez ML, Moreno A, Narvaez I, Guilera M; EVEROLIVER study group.

Liver Transpl. 2015 Aug;21(8):1056-65. doi: 10.1002/lt.24172.

35.

Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients.

Cuervas-Mons V, Herrero JI, Gomez MA, González-Pinto I, Serrano T, de la Mata M, Fabregat J, Gastaca M, Bilbao I, Varo E, Sánchez-Antolín G, Rodrigo J, Espinosa MD.

Clin Transplant. 2015 Aug;29(8):667-77. doi: 10.1111/ctr.12557. Epub 2015 Jun 29.

PMID:
25924549
36.

Analysis of adult 20-year survivors after liver transplantation.

Dopazo C, Bilbao I, Castells LL, Sapisochin G, Moreiras C, Campos-Varela I, Echeverri J, Caralt M, Lázaro JL, Charco R.

Hepatol Int. 2015 Jul;9(3):461-70. doi: 10.1007/s12072-014-9577-x. Epub 2014 Sep 18.

37.

Neutrophils scan for activated platelets to initiate inflammation.

Sreeramkumar V, Adrover JM, Ballesteros I, Cuartero MI, Rossaint J, Bilbao I, Nácher M, Pitaval C, Radovanovic I, Fukui Y, McEver RP, Filippi MD, Lizasoain I, Ruiz-Cabello J, Zarbock A, Moro MA, Hidalgo A.

Science. 2014 Dec 5;346(6214):1234-8. doi: 10.1126/science.1256478. Epub 2014 Dec 4.

38.

Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.

Sapisochin G, Goldaracena N, Astete S, Laurence JM, Davidson D, Rafael E, Castells L, Sandroussi C, Bilbao I, Dopazo C, Grant DR, Lázaro JL, Caralt M, Ghanekar A, McGilvray ID, Lilly L, Cattral MS, Selzner M, Charco R, Greig PD.

Ann Surg Oncol. 2015 Jul;22(7):2286-94. doi: 10.1245/s10434-014-4273-6. Epub 2014 Dec 4.

PMID:
25472651
39.

Immunosuppression based on everolimus in liver transplant recipients with severe early post-transplantation neurotoxicity.

Bilbao I, Dopazo C, Castells L, Lazaro J, Caralt M, Sapisochin G, Charco R.

Transplant Proc. 2014 Nov;46(9):3104-7. doi: 10.1016/j.transproceed.2014.10.001.

PMID:
25420835
40.

Phosphatidylcholine-coated iron oxide nanomicelles for in vivo prolonged circulation time with an antibiofouling protein corona.

Groult H, Ruiz-Cabello J, Lechuga-Vieco AV, Mateo J, Benito M, Bilbao I, Martínez-Alcázar MP, Lopez JA, Vázquez J, Herranz FF.

Chemistry. 2014 Dec 8;20(50):16662-71. doi: 10.1002/chem.201404221. Epub 2014 Oct 15.

PMID:
25319949
41.

[Early detection, prevention and management of renal failure in liver transplantation].

Castells L, Baliellas C, Bilbao I, Cantarell C, Cruzado JM, Esforzado N, García-Valdecasas JC, Lladó L, Rimola A, Serón D, Oppenheimer F.

Gastroenterol Hepatol. 2014 Oct;37(8):480-91. doi: 10.1016/j.gastrohep.2013.11.006. Epub 2014 Jul 22. Spanish.

PMID:
25060591
42.

Multiple indications for everolimus after liver transplantation in current clinical practice.

Bilbao I, Dopazo C, Lazaro J, Castells L, Caralt M, Sapisochin G, Charco R.

World J Transplant. 2014 Jun 24;4(2):122-32. doi: 10.5500/wjt.v4.i2.122.

43.

Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: a cohort study.

Pérez-Cameo C, Vargas V, Castells L, Bilbao I, Campos-Varela I, Gavaldà J, Pahissa A, Len O.

Liver Transpl. 2014 Jul;20(7):856-63. doi: 10.1002/lt.23889. Epub 2014 May 26.

44.

Gene silencing of SOCS3 by siRNA intranasal delivery inhibits asthma phenotype in mice.

Zafra MP, Mazzeo C, Gámez C, Rodriguez Marco A, de Zulueta A, Sanz V, Bilbao I, Ruiz-Cabello J, Zubeldia JM, del Pozo V.

PLoS One. 2014 Mar 17;9(3):e91996. doi: 10.1371/journal.pone.0091996. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105924.

45.

Low plasma levels of antithrombin III in the early post-operative period following pediatric liver transplantation: should they be replaced? A single-center pilot study.

Quintero J, Ortega J, Miserachs M, Bueno J, Bilbao I, Charco R.

Pediatr Transplant. 2014 Mar;18(2):185-9. doi: 10.1111/petr.12217. Epub 2014 Jan 20.

PMID:
24438318
46.

Liver biopsy-related infection in liver transplant recipients: A current matter of concern?

Sánchez CL, Len O, Gavalda J, Bilbao I, Castells L, Gelabert MA, Allende H, Pahissa A.

Liver Transpl. 2014 May;20(5):552-6. doi: 10.1002/lt.23817. Epub 2014 Jan 27.

47.

Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure.

Quintero J, Miserachs M, Ortega J, Bueno J, Dopazo C, Bilbao I, Castells L, Charco R.

Liver Int. 2014 May;34(5):689-94. doi: 10.1111/liv.12298. Epub 2013 Sep 24.

PMID:
24112412
48.

Sporadic hyperekplexia presenting with an ataxic gait.

Rouco I, Bilbao I, Losada J, Maestro I, Zarranz JJ.

J Clin Neurosci. 2014 Feb;21(2):345-6. doi: 10.1016/j.jocn.2013.03.025. Epub 2013 Sep 17.

PMID:
24054400
49.

Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.

Sapisochin G, Castells L, Dopazo C, Bilbao I, Minguez B, Lázaro JL, Allende H, Balsells J, Caralt M, Charco R.

Ann Surg Oncol. 2013 Apr;20(4):1194-202. doi: 10.1245/s10434-012-2655-1. Epub 2012 Sep 11.

PMID:
22965574
50.

Twelve automated thresholding methods for segmentation of PET images: a phantom study.

Prieto E, Lecumberri P, Pagola M, Gómez M, Bilbao I, Ecay M, Peñuelas I, Martí-Climent JM.

Phys Med Biol. 2012 Jun 21;57(12):3963-80. doi: 10.1088/0031-9155/57/12/3963. Epub 2012 May 31.

PMID:
22647928

Supplemental Content

Loading ...
Support Center